Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
International Journal of Medicinal Mushrooms
Factor de Impacto: 1.423 Factor de Impacto de 5 años: 1.525 SJR: 0.431 SNIP: 0.661 CiteScore™: 1.38

ISSN Imprimir: 1521-9437
ISSN En Línea: 1940-4344

Volumen 21, 2019 Volumen 20, 2018 Volumen 19, 2017 Volumen 18, 2016 Volumen 17, 2015 Volumen 16, 2014 Volumen 15, 2013 Volumen 14, 2012 Volumen 13, 2011 Volumen 12, 2010 Volumen 11, 2009 Volumen 10, 2008 Volumen 9, 2007 Volumen 8, 2006 Volumen 7, 2005 Volumen 6, 2004 Volumen 5, 2003 Volumen 4, 2002 Volumen 3, 2001 Volumen 2, 2000 Volumen 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushrooms.2019031508
pages 755-763

Bioactivity-Guided Isolation of Acetylcholinesterase Inhibitor from Ganoderma mediosinense (Agaricomycetes)

Arshdeep Kaur
Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, Punjab, India
Kudrat Randhawa
Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, Punjab, India
Varinder Singh
Chitkara College of Pharmacy, Chitkara University, Punjab, India
Richa Shri
Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, Punjab, India


The involvement of high acetylcholinesterase (AChE) activity and oxidative stress in the brain is well documented in the progression of dementia. Thus, finding a drug with both AChE-inhibitory and antioxidant activities could be beneficial in treating dementia. We previously reported the AChE-inhibitory and antioxidant-mediated antiamnestic effects of a hydromethanol extract from Ganoderma mediosinense (HME), which we evaluated using in vitro and in vivo models. Mycochemical screening of HME showed the presence of phenols. Building on those findings, this study was designed to isolate the compound responsible for the AChE-inhibitory and antioxidant activities of G. mediosinense. The HME was fractionated sequentially with solvents−namely, hexane, chloroform, and ethyl acetate. The prepared fractions were evaluated by using Ellman and DPPH-inhibitory assays in vitro. Among the fractions, the ethyl acetate fraction showed appreciable AChE-inhibitory (half-maximal inhibitory concentration [IC50] 0.81 ± 0.04 mg/mL) and DPPH scavenging (IC50 2.04 ± 0.77 μg/mL) activities; therefore it was subjected to flash chromatography, which separated 9 subfractions. Subfraction 7 showed marked activity in inhibiting AChE (IC50 0.10 ± 0.02 mg/mL) and free radicals (IC50 1.22 ± 0.04 μg/mL). Purification of subfraction 7 yielded a white compound, AK1. This was characterized as gallic acid by using Fourier-transform infrared, nuclear magnetic resonance, and mass spectral studies. This study shows that gallic acid, a well-recognized phenolic acid, is responsible for the AChE-inhibitory and DPPH scavenging activities of G. mediosinense.


  1. Awasthi M, Singh S, Pandey VP, Dwivedi UN. Alzheimer's disease: an overview of amyloid beta dependent pathogenesis and its therapeutic implications along with in silico approaches emphasizing the role of natural products. J Neurol Sci. 2016;361:256-71.

  2. Auld DS, Kornecook TJ, Bastianetto S, Quirion R. Alzheimer's disease and the basal forebrain cholinergic system: relations to P-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol. 2002;68(3):209-45.

  3. Colovic MB, Krstic DZ, Lazarevic-Pasti TD, Bondzic AM, Vasic VM. Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol. 2013;11(3):315-35.

  4. Singh M, Kaur M, Kukreja H, Chugh R, Silakari O, Singh D. Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection. Eur J Med Chem. 2013;70:165-88.

  5. Wachtel-Galor S, Yuen J, Buswell JA, Benzie IFF. Ganoderma lucidum (lingzhi or reishi): a medicinal mushroom. In: Benzie IFF, Wachtel-Galor S, editors. Herbal medicine: biomolecular and clinical aspects. 2nd ed. Boca Raton (FL): CRC Press; 2011.

  6. Chang ST, Buswell JA. Mushroom nutraceuticals. World J Microbiol Biotechnol. 1996;12(5):473-6.

  7. Kabir Y, Kimura S, Tamura T. Dietary effect of Ganoderma lucidum mushroom on blood pressure and lipid levels in spontaneously hypertensive rats (SHR). J Nutr Sci Vitaminol. 1988;34(4):433-8.

  8. Soccol CR, Bissoqui LY, Rodrigues C, Rubel R, Sella SR, Leifa F, de Souza Vandenberghe LP, Soccol VT. Pharmacological properties of biocompounds from spores of the lingzhi or reishi medicinal mushroom Ganoderma lucidum (Agaricomycetes): a review. Int J Med Mushrooms. 2016;18(9):757-67.

  9. Gerber AL, Smania A Jr, Monache FD, Biacchi N Jr, Smania ED. Triterpenes and sterols from Ganoderma australe (Fr.) Pat. (Aphyllophoromycetidae). Int J Med Mushrooms. 2000;2(4):303-11.

  10. Shi Y, Sun J, He H, Guo H, Zhang S. Hepatoprotective effects of Ganoderma lucidum peptides against D-galactosamine-induced liver injury in mice. J Ethnopharmacol. 2008;117(3):415-9.

  11. Tie L, Yang HQ, An Y, Liu SQ, Han J, Xu Y, Hu M, Li WD, Chen AF, Lin ZB, Li XJ. Ganoderma lucidum polysaccharide accelerates refractory wound healing by inhibition of mitochondrial oxidative stress in type 1 diabetes. Cell Physiol Biochem. 2012;29(3-4):583-94.

  12. Kaur R, Singh V, Shri R. Anti-amnesic effects of Ganoderma species: a possible cholinergic and antioxidant mechanism. Biomed Pharmacother. 2017;92:1055-61.

  13. Farnsworth NR. Biological and phytochemical screening of plants. J Pharm Sci. 1966;55(3):225-76.

  14. Ellman GL, Courtney KD, Andres V Jr, Feather-stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7(2):88-95.

  15. Blois MS. Antioxidant determinations by the use of a stable free radical. Nature. 1958;181:1199-200.

  16. Yiannopoulou KG, Papageorgiou SG. Current and future treatments for Alzheimer's disease. Ther Adv Neurol Disord. 2013;6(1):19-33.

  17. Francis PT, Palmer AM, Snape M, Wilcock GK. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatry. 1999;66(2):137-47.

  18. Pinto T, Lanctot KL, Herrmann N. Revisiting the cholinergic hypothesis of behavioral and psychological symptoms in dementia of the Alzheimer's type. Ageing Res Rev. 2011;10(4):404-12.

  19. Bennett S, Grant MM, Aldred S. Oxidative stress in vascular dementia and Alzheimer's disease: a common pathology. J Alzheimers Dis. 2009;17(2):245-57.

  20. Gella A, Durany N. Oxidative stress in Alzheimer disease. Cell Adh Migr. 2009;3(1):88-93.

  21. Garcia-Blanco A, Baquero M, Vento M, Gil E, Bataller L, Chafer-Pericas C. Potential oxidative stress biomarkers of mild cognitive impairment due to Alzheimer disease. J Neurol Sci. 2017;373:295-302.

  22. Luca M, Luca A, Calandra C. The role of oxidative damage in the pathogenesis and progression of Alzheimer's disease and vascular dementia. Oxid Med Cell Longev. 2015;2015:504678.

  23. Huang WJ, Zhang XI, Chen WW. Role of oxidative stress in Alzheimer's disease. Biomed Rep. 2016;4(5):519-22.

  24. Chanwitheesuk A, Teerawutgulrag A, Kilburn JD, Rakariyatham N. Antimicrobial gallic acid from Caesalpinia mimosoides Lamk. Food Chem. 2007;100(3):1044-8.

  25. Sarria-Villa RA, Gallo-Corredor JA, Paez MI. Isolation of catechin and gallic acid from Colombian bark of Pinus patula. Chem Sci J. 2017;8:174.

  26. Veljovic S, Veljovic M, Nikicevic N, Despotovic S, Radulovic S, Niksic M, Filipovic L. Chemical composition, anti-proliferative and antioxidant activity of differently processed Ganoderma lucidum ethanol extracts. J Food Sci Technol. 2017;54(5):1312-20.

  27. Kim MY, Seguin P, Ahn JK, Kim JJ, Chun SC, Kim EH, Seo SH, Kang EY, Kim SL, Park YJ, Ro HM. Phenolic compound concentration and antioxidant activities of edible and medicinal mushrooms from Korea. J Agric Food Chem. 2008;56:7265-70.

  28. Lin S, Ching LT, Ke X, Cheung PC. Comparison of the composition and antioxidant activities of phenolics from the fruiting bodies of cultivated Asian culinary-medicinal mushrooms. Int J Med Mushrooms. 2016;18(10):871-81.

  29. Gaur T, Rao PB. Analysis of antibacterial activity and bioactive compounds of the giant mushroom, Macrocybe gigantea (Agaricomycetes), from India. Int J Med Mushrooms. 2017;19(12):1083-92.

  30. Cilerdzic J, Stajic M, Vukojevic J, Duletic-Lausevic S. Oxidative stress and species of genus Ganoderma (higher Basidiomycetes). Int J Med Mushrooms. 2013;15(1):21-8.

  31. Roseiro LB, Rauter AP, Serralheiro ML. Polyphenols as acetylcholinesterase inhibitors: structural specificity and impact on human disease. Nutr Aging (Amst). 2012;1(2):99-111.

  32. Murray AP, Faraoni MB, Castro MJ, Alza NP, Cavallaro V. Natural AChE inhibitors from plants and their contribution to Alzheimer's disease therapy. Curr Neuropharmacol. 2013;11(4):388-413.

  33. Hajipour S, Sarkaki A, Farbood Y, Eidi A, Mortazavi P, Valizadeh Z. Effect of gallic acid on dementia type of Alzheimer disease in rats: electrophysiological and histological studies. Basic Clin Neurosci. 2016;7(2):97-106.

  34. Nagpal K, Singh SK, Mishra DN. Nanoparticle mediated brain targeted delivery of gallic acid: in vivo behavioral and biochemical studies for protection against scopolamine-induced amnesia. Drug Deliv. 2013;20(3-4):112-9.

Articles with similar content:

Biological Activities of the Polysaccharides Produced from Different Sources of Xylaria nigripes (Ascomycetes), a Chinese Medicinal Fungus
International Journal of Medicinal Mushrooms, Vol.17, 2015, issue 2
Mu-Chun Hung, Fang-Yi Lin, Wai-Jane Ho, Zeng-Chin Liang, Tai-Hao Hsu, Shih-Liang Chang, Chia-Chun Tsai, Chang-Wei Hsieh
Secondary Metabolites and Antioxidant Capacity of the Tunisian Lichen Diploschistes ocellatus (Ascomycota)
International Journal of Medicinal Mushrooms, Vol.21, 2019, issue 8
Samira Aschi-Smiti, Mohamed Mendili, Marwa Bannour, Maria Eduarda M. Araújo, Ayda Khadhria, Mark R. D. Seaward
Antioxidant Properties of Extracts of Wild Medicinal Mushroom Species from Croatia
International Journal of Medicinal Mushrooms, Vol.13, 2011, issue 3
Dunja Samec, Jasenka Piljac-Zegarac, Ante Piljac, Armin Mesic, Zdenko Tkalcec
Antioxidant and Antiproliferative Potential of Fruiting Bodies of the Wild-Growing King Bolete Mushroom, Boletus edulis (Agaricomycetes), from Western Serbia
International Journal of Medicinal Mushrooms, Vol.19, 2017, issue 1
Nebojsa llic, Sonja Kaisarevic, Aleksandra Novakovic, Maja Karaman, Tanja Radusin
Antioxidant, Anticancer, Antimicrobial, and Antibiofilm Properties of the Culinary-Medicinal Fairy Ring Mushroom, Marasmius oreades (Agaricomycetes)
International Journal of Medicinal Mushrooms, Vol.21, 2019, issue 6
Nergiz Demirtas, Naznoosh Shomali, Okan Onar, Ozlem Yildirim, Basar Karaca, Ilgaz Akata, Arzu Coleri Cihan